Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case

被引：19
作者：
Connor, Bradley A. [1 ,2 ,3 ]
Couto-Rodriguez, Mara [4 ]
Barrows, Joseph E. [4 ]
Gardner, Morgan [2 ,3 ]
Rogova, Marina [2 ,3 ]
O'Hara, Niamh B. [4 ,5 ]
Nagy-Szakal, Dorottya [4 ,5 ]
机构：
[1] Weill Cornell Med, New York, NY 10021 USA
[2] New York Ctr Travel & Trop Med, New York, NY 10022 USA
[3] GeoSentinel, New York, NY 12201 USA
[4] Biotia Inc, New York, NY USA
[5] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Coll Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2021年 / 110卷
关键词：
B; 1; 617; 2; Delta variant; SARS-CoV-2; COVID-19; variant of concern; breakthrough; monoclonal antibody therapy; bamlanivimab; etesevimab;
D O I：
10.1016/j.ijid.2021.07.029
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We present two Delta (B.1.617.2) vaccine breakthrough individuals, a father and son living in separate households. The older, 63-year-old patient's symptoms were severe enough to require hospitalization. De-spite having a high titer of anti-spike IgG in his serum, his symptoms resolved within 24 hours following monoclonal antibody (bamlanivimab/etesevimab) therapy. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码：232 / 234
页数：3
相关论文
共 50 条
  • [31] Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
    Ren, Wenlin
    Ju, Xiaohui
    Gong, Mingli
    Lan, Jun
    Yu, Yanying
    Long, Quanxin
    Kenney, Devin J.
    O'Connell, Aoife K.
    Zhang, Yu
    Zhong, Jin
    Zhong, Guocai
    Douam, Florian
    Wang, Xinquan
    Huang, Ailong
    Zhang, Rong
    Ding, Qiang
    [J]. MBIO, 2022, 13 (02):
  • [32] mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
    Park, Hanul
    Park, Young Joon
    Lee, Sang Eun
    Lee, Min Jei
    Ahn, Hyungtae
    [J]. OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2022, 13 (06) : 435 - 442
  • [33] Clinical and Laboratory Differences between Delta and UK Variants of SARS-CoV-2: B.1.617.2 and B.1.1.7
    Koc, Ibrahim
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 257 (04) : 273 - 281
  • [34] Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus
    Mak, Gannon C. K.
    Lau, Stephen S. Y.
    Wong, Kitty K. Y.
    Chow, Nancy L. S.
    Lau, Chi-Shan
    Lam, Edman T. K.
    Ng, Ken H. L.
    Chan, Rickjason C. W.
    [J]. FUTURE VIROLOGY, 2022, 17 (06) : 387 - 392
  • [35] SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
    Khemiri, Haifa
    Ayouni, Kaouther
    Triki, Henda
    Haddad-Boubaker, Sondes
    [J]. VIROLOGY JOURNAL, 2022, 19 (01)
  • [36] COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
    Kumar, Nitya
    Quadri, Suha
    AlAwadhi, Abdulla Ismaeel
    AlQahtani, Manaf
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
    Haifa Khemiri
    Kaouther Ayouni
    Henda Triki
    Sondes Haddad-Boubaker
    [J]. Virology Journal, 19
  • [38] Clinical and Virological Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta) Variant: A Prospective Cohort Study
    Park, Sunghee
    Lim, So Yun
    Kim, Ji Yeun
    Park, Heedo
    Lim, Joon Seo
    Bae, Seongman
    Kim, Jeonghun
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Choi, Sang-Ho
    Lee, Sang-Oh
    Kim, Yang Soo
    Park, Man-Seong
    Kim, Sung-Han
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E27 - E34
  • [39] Increased pathogenicity and aerosol transmission for one SARS-CoV-2 B.1.617.2 Delta variant over the wild-type strain in hamsters
    Zhang, Xinghai
    Chen, Shaohong
    Cao, Zengguo
    Yao, Yanfeng
    Yu, Junping
    Zhou, Junhui
    Gao, Ge
    He, Ping
    Dong, Zhuo
    Zhong, Jie
    Luo, Jing
    Wei, Hongping
    Zhang, Huajun
    [J]. VIROLOGICA SINICA, 2022, 37 (06) : 796 - 803
  • [40] Functionality of Monoclonal Antibody Therapy in SARS-CoV-2
    Ali, Ruhma
    Patel, Aditya
    Waqas, Muhammad A.
    Trivedi, Krunal
    Slim, Jihad
    [J]. JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 380 - 385
12345